U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432737) titled 'One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures' on Feb. 11.
Brief Summary: The goal of this clinical trial is to learn whether giving one dose or two doses of tranexamic acid can safely lower blood loss in older adults having surgery for certain hip fractures. The study includes adults aged 65 years or older who need surgery for pertrochanteric or subtrochanteric hip fractures.
The main questions the study aims to answer are:
* Does giving two doses of tranexamic acid lower the need for blood transfusions compared to one dose?
* Does tranexamic acid help keep hemoglobin levels higher aft...